High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up

  • Dirk SandnerEmail author
  • Erdmuth Herbrig
  • Katrin Engelmann
Clinical Investigation



The high-density silicone oil (Densiron 68), a mixture of F6H8 with silicone oil, seems to be a therapeutic option, at least in selected patients with complex inferior retinal re-detachment, where standard procedures have already failed. In an interventional case series we used Densiron as a primary endotamponade.


Twelve eyes of 12 patients aged 31 years to 85 years with inferior complex rhegmatogenous retinal detachment with secondary proliferative vitreoretinopathy (PVR) grades CP2 to CA8 were included. Surgical techniques (pars plana vitrectomy, membrane peeling, retinotomy, retinectomy, endophotocoagulation, cryocoagulation, endotamponade) did not include a scleral buckling procedure (except one eye). Mean duration of the Densiron endotamponade was 78.3  ±  29.74 days, with a mean follow up after removal of 400.6 ± 85.4 days.


After Densiron removal, four patients (33.3%) showed a stable reattached retina without further interventions, while, in six patients (50%), recurrent retinal re-detachment appeared during endotamponade, generally within 2 months. One patient (8.3%) developed re-detachment 5 months after Densiron removal. One eye (8.3%) lost light perception due to severe intraretinal fibrosis with chronic hypotonia, despite complete retinal re-attachment. Visual acuity improved from mean logarithm of the minimum angle of resolution (logMAR) of 2.95 ± 1.21 to 1.87 ± 1.32 (statistically significant, P = 0.022). Side effects included temporary inflammatory reaction/fibrin accumulation (n = 2/2), moderate-to-severe intraretinal fibrosis (n = 3), elevated intraocular pressure (IOP) (n = 3), emulsification (n = 2), sterile hypopyon (n = 1), vitreous haemorrhage (n = 1) and chronic hypotony (n = 1).


Primary anatomical success rate of 33.3% was less encouraging than as expected. Especially, re-detachments within the posterior staphyloma in highly myopic patients were common during Densiron endotamponade. However, the surgical success increased to 75% after re-intervention, even without the use of an additional encircling band. The observed adverse effects and the functional outcomes do not contraindicate the use of Densiron as an internal tamponade for a period of 3 months.


Retinal detachment Proliferative vitreoretinopathy Heavy silicone oil Perfluorohexyloctane Ocular endotamponade 


  1. 1.
    Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R (1991) Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina 11:367–374PubMedGoogle Scholar
  2. 2.
    Chang S, Zimmerman NJ, Iwamoto T, Ortiz R, Faris D (1987) Experimental vitreous replacement with perfluorotributylamine. Am J Ophthalmol 103:29–37PubMedGoogle Scholar
  3. 3.
    Dresp JH, Menz D-H (2005) Interaction of different ocular endotamponades as a risk factor for silicone oil emulsification. Retina 25:902–910PubMedCrossRefGoogle Scholar
  4. 4.
    Falkner CI, Binder S, Kruger A (2001) Outcome after silicone oil removal. Br J Ophthalmol 85:1324–1327PubMedCrossRefGoogle Scholar
  5. 5.
    Fisk MJ, Cairns JD (1995) Silicone oil insertion. A review of 127 consecutive cases. Aust N Z J Ophthalmol 23:25–32PubMedGoogle Scholar
  6. 6.
    Flaxel CJ, Mitchell SM, Aylward GW (2000) Visual outcome after silicone oil removal and recurrent retinal detachment repair. Eye 14:834–838PubMedGoogle Scholar
  7. 7.
    Gabel VP, Kampik A, Gabel C, Spiegel D (1987) Silicone oil with high specific gravity for intraocular use. Br J Ophthalmol 71:262–267PubMedGoogle Scholar
  8. 8.
    Gerding H, Kolck A (2004) [Perfluorohexyloctane as internal tamponade in patients with complicated retinal detachment. Results after 6 months]. Ophthalmologe 101:255–262PubMedCrossRefGoogle Scholar
  9. 9.
    Gremillion CM Jr, Peyman GA, Liu KR, Naguib KS (1990) Fluorosilicone oil in the treatment of retinal detachment. Br J Ophthalmol 74:643–646PubMedGoogle Scholar
  10. 10.
    Hiscott P, Magee RM, Colthurst M, Lois N, Wong D (2001) Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade. Br J Ophthalmol 85:179–183PubMedCrossRefGoogle Scholar
  11. 11.
    Hoerauf H, Kobuch K, Dresp J, Menz DH (2001) Combined use of partially fluorinated alkanes, perfluorocarbon liquids and silicone oil: an experimental study. Graefes Arch Clin Exp Ophthalmol 239:373–381PubMedGoogle Scholar
  12. 12.
    Jonas JB, Knorr HL, Rank RM, Budde WM (2001) Retinal redetachment after removal of intraocular silicone oil tamponade. Br J Ophthalmol 85:1203–1207PubMedCrossRefGoogle Scholar
  13. 13.
    Kampik A, Hoing C, Heidenkummer HP (1992) Problems and timing in the removal of silicone oil. Retina 12:S11–S16PubMedCrossRefGoogle Scholar
  14. 14.
    Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N, Schrage NF (2002) Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 133:95–101PubMedCrossRefGoogle Scholar
  15. 15.
    Kobuch K, Menz IH, Hoerauf H, Dresp JH, Gabel VP (2001) New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 239:635–642PubMedGoogle Scholar
  16. 16.
    La Heij EC, Hendrikse F, Kessels AG (2001) Results and complications of temporary silicone oil tamponade in patients with complicated retinal detachments. Retina 21:107–114PubMedCrossRefGoogle Scholar
  17. 17.
    Lucke K, Laqua H (1990) Proliferative vitreoretinopathy silicone oil in the treatment of complicated retinal detachments. Springer, Berlin Heidelberg New York, pp 81–88Google Scholar
  18. 18.
    Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM (1991) An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 112:159–165PubMedGoogle Scholar
  19. 19.
    Malchiodi-Albedi F, Matteucci A, Formisano G, Paradisi S, Carnovale-Scalzo G, Perilli R, Scorcia G, Caiazza S (2003) Perfluorohexyloctane (F6H8) induces structural modifications and increases apoptosis in rat primary retinal cultures. J Biomed Mater Res B Appl Biomater 65:133–136PubMedCrossRefGoogle Scholar
  20. 20.
    Meinert H, Roy T (2000) Semifluorinated alkanes—a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol 10:189–197PubMedGoogle Scholar
  21. 21.
    Mertens S, Bednarz J, Engelmann K (2002) Evidence of toxic side effects of perfluorohexyloctane after vitreoretinal surgery as well as in previously established in vitro models with ocular cell types. Graefes Arch Clin Exp Ophthalmol 240:989–995Google Scholar
  22. 22.
    Miyamoto K, Refojo MF, Tolentino FI, Fournier GA, Albert DM (1984) Perfluoroether liquid as a long-term vitreous substitute. An experimental study. Retina 4:264–268PubMedCrossRefGoogle Scholar
  23. 23.
    Nabih M, Peyman GA, Clark LC Jr, Hoffman RE, Miceli M, Abou-Steit M, Tawakol M, Liu KR (1989) Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: a preliminary report. Ophthalmic Surg 20:286–293PubMedGoogle Scholar
  24. 24.
    Pastor JC, Mendez MC, de la Fuente MA, Coco RM, Garcia-Arumi J, Rodriguez de la Rua E, Fernandez N, Saornil MA, Gayoso MJ (2006) Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening. Ophthalmic Res 38:193–200PubMedCrossRefGoogle Scholar
  25. 25.
    Roider J, Hoerauf H, Kobuch K, Gabel VP (2002) Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligomers) in complicated retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 240:965–971PubMedGoogle Scholar
  26. 26.
    Sandner D, Engelmann K (2006) First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment Graefes Arch Clin Exp Ophthalmol 244:609–619PubMedCrossRefGoogle Scholar
  27. 27.
    Schatz B, El-Shabrawi Y, Haas A, Langmann G (2004) Adverse side effects with perfluorohexyloctane as a long-term tamponade agent in complicated vitreoretinal surgery. Retina 24:567–573PubMedCrossRefGoogle Scholar
  28. 28.
    Schatz B, Langmann G, Faulborn J (2001) Erfahrungen mit Fluoron (F6H8) als Tamponade in der komplexen Netzhautchirurgie. Spektrum Augenheilkd 15:238–241CrossRefGoogle Scholar
  29. 29.
    Scott IU, Flynn HW, Lai M, et al (2000) First operation anatomic success and other predictors of postoperative vision after complex retinal detachment repair with vitrectomy and silicone oil tamponade. Am J Ophthalmol 130:745–750PubMedCrossRefGoogle Scholar
  30. 30.
    Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, Charteris DG (2005) Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 46:329–342PubMedCrossRefGoogle Scholar
  31. 31.
    Sharma T, Gopal L, Shanmugam MP, et al (2002) Management of recurrent retinal detachment in silicone oil-filled eyes. Retina 22:153–157PubMedCrossRefGoogle Scholar
  32. 32.
    Sparrow JR, Matthews GP, Iwamoto T, Ross R, Gershbein A, Chang S (1993) Retinal tolerance to intravitreal perfluoroethylcyclohexane liquid in the rabbit. Retina 13:56–62PubMedCrossRefGoogle Scholar
  33. 33.
    Stolba U, Krepler K, Pflug R, Velikay M, Wedrich A, Binder S (1997) Experimental vitreous and aqueous replacement with perfluorophenanthrene. Clinical, histologic, and electrophysiologic results. Retina 17:146–153PubMedCrossRefGoogle Scholar
  34. 34.
    Stolba U, Krepler K, Velikay-Parel M, Binder S (2004) The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution. Graefes Arch Clin Exp Ophthalmol 242:931–936PubMedCrossRefGoogle Scholar
  35. 35.
    Theelen T, Tilanus M, Klevering BJ (2004) Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch Clin Exp Ophthalmol 242:617–620PubMedGoogle Scholar
  36. 36.
    Tognetto D, Minutola D, Sanguinetti G, Ravalico G (2005) Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: a pilot study. Ophthalmology 112:1574–1578, SepPubMedCrossRefGoogle Scholar
  37. 37.
    Velikay M, Wedrich A, Stolba U, Datlinger P, Li Y, Binder S (1993) Experimental long-term vitreous replacement with purified and nonpurified perfluorodecalin. Am J Ophthalmol 116:565–570PubMedGoogle Scholar
  38. 38.
    Vote B, Wheen L, Cluroe A, Teoh H, McGeorge A (2003) Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Exp Ophthalmol 31:408–414CrossRefGoogle Scholar
  39. 39.
    Wolf S, Schon V, Meier P, Wiedemann P (2003) Silicone oil-RMN3 mixture (“heavy silicone oil”) as internal tamponade for complicated retinal detachment. Retina 23:335–342PubMedCrossRefGoogle Scholar
  40. 40.
    Wong D, Van Meurs JC, et al (2005) A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 89:662–665PubMedCrossRefGoogle Scholar
  41. 41.
    Wong D, Williams R, Stappler T, Groenewald C (2005) What pressure is exerted on the retina by heavy tamponade agents? Graefes Arch Clin Exp Ophthalmol 243:474–477PubMedCrossRefGoogle Scholar
  42. 42.
    Yamamoto S, Takeuchi S (2000) Silicone oil and fluorosilicone. Semin Ophthalmol 15:15–24PubMedCrossRefGoogle Scholar
  43. 43.
    Zeana D, Becker J, Kuckelkorn R, Kirchhof B (1999) Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol 23:17–24PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Dirk Sandner
    • 1
    Email author
  • Erdmuth Herbrig
    • 1
  • Katrin Engelmann
    • 2
  1. 1.Department of Ophthalmology, Medical Faculty “Carl Gustav Carus”Dresden University of TechnologyDresdenGermany
  2. 2.Department of OphthalmologyChemnitz Clinical CentreChemnitzGermany

Personalised recommendations